HCA Healthcare, Inc. (HCA)
Healthcare › Services-General Medical & Surgical Hospitals, NEC
Price History
Feb 9, 2026 — Apr 4, 2026Investment Snapshot
- P/E of 18.2 — reasonable valuation
- Piotroski F-Score 6/9 — moderate financial health
- Loss-making — negative ROE of -745.6%
- Revenue growing at 7% annually
HCA Healthcare, Inc. (HCA) is a Healthcare company operating in Services-General Medical & Surgical Hospitals, NEC, listed on the NYSE , with a market capitalisation of $112.3 billion . Key value metrics: P/E ratio 18.2, Piotroski F-Score 6 out of 9 (moderate financial health) .
Value Score
Key Metrics
Current vs 5-Year Average
Based on 5 years of SEC filingsRevenue & Net Income
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
HCA Healthcare, Inc. — Fundamental Analysis Summary
HCA Healthcare, Inc. (HCA) trades at a trailing P/E of 18.2x — 28% below the Healthcare sector average of 25.3x.
On financial health, HCA shows a moderate Piotroski F-Score of 6/9, and negative return on equity of -745.6% (sector average: -19.8%).
StockPik's composite Value Score for HCA is 64/100 — an above-average value rating. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
HCA shows revenue growing at 7% year-over-year, with earnings growing at 18%.
HCA pays a modest dividend yield of 0.6%.